theophylline has been researched along with Kidney Diseases in 54 studies
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Total body clearance (ClT) of theophylline was examined in 12 markedly obese patients and related to total body weight (TBW) and ideal body weight (IBW)." | 7.66 | Theophylline clearance: effect of marked obesity. ( Bauer, LA; Blouin, RA; Elgert, JF, 1980) |
| "Total body clearance (ClT) of theophylline was examined in 12 markedly obese patients and related to total body weight (TBW) and ideal body weight (IBW)." | 3.66 | Theophylline clearance: effect of marked obesity. ( Bauer, LA; Blouin, RA; Elgert, JF, 1980) |
| " Chemotherapeutic patients who received cisplatin at a dosage of at least 50 mg/m 2 alone or in combination with other chemotherapy agent(s) were included in the study." | 2.79 | The protective effect of theophyline in cisplatin nephrotoxicity. ( Ghorbani, A; Golzari, K; Hayati, F; Khanzadeh, A; Motemednia, F; Mousavi, MB; Mousavi, SS; Shahbazian, H; Valavi, E; Zadeh, MH, 2014) |
| "Theophylline seems to be an effective prophylaxis against CIN for moderate- and high-risk patients undergoing coronary angiography or angioplasty." | 2.77 | Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures. ( Bilasy, ME; Ismail, HM; Maklady, FA; Oraby, MA, 2012) |
| "Adenosine is a crucial mediator of contrast-induced nephropathy (CIN; an increase in serum creatinine of >or=0." | 2.71 | Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. ( Classen, M; Hennig, M; Huber, W; Ilgmann, K; Lutilsky, L; Page, M; Schipek, C; Schömig, A; Schweigart, U; Seyfarth, M; Valina, C; Wacker, A, 2003) |
| " Patients received cisplatin at a dosage of 50 mg/m(2) either combined with etoposide, ifosfamide, and epirubicin or with paclitaxel and 5-fluorouracil/folinic acid with the usual precautions, including a standard hydration scheme before application of cisplatin in both arms." | 2.71 | Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial. ( Benoehr, P; Bokemeyer, C; Grenz, A; Hartmann, JT; Krueth, P; Osswald, H, 2005) |
| "Aminophylline has been shown to reduce severe renal dysfunction in neonates after perinatal asphyxia." | 1.62 | Aminophylline for renal protection in neonatal hypoxic-ischemic encephalopathy in the era of therapeutic hypothermia. ( Cho, SH; Chock, VY; Frymoyer, A, 2021) |
| "The acute renal effects of hypoxemia and the ability of the co-administration of an angiotensin converting enzyme inhibitor (perindoprilat) and an adenosine receptor antagonist (theophylline) to prevent these effects were assessed in anesthetized and mechanically-ventilated rabbits." | 1.31 | Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit. ( Gouyon, JB; Guignard, JP; Huet, F; Prévot, A; Semama, DS, 2002) |
| " These results suggested that CsA dosage could be reduced and the renal tubular damages could be lowered when DIL was used." | 1.29 | [Basic studies on the prevention of cyclosporin A induced nephrotoxicity]. ( Kudoh, S; Satoh, A, 1994) |
| "When adenosine deaminase was added to the recirculating perfusate in 8 experiments, severe damage to mTAL cells adjacent to the inner medulla was significantly exacerbated to involve 89." | 1.28 | Relation of adenosine to medullary injury in the perfused rat kidney. ( Brezis, M; Epstein, FH; Galicka-Piskorska, G; Rosen, S; Silva, P; Spokes, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (18.52) | 18.7374 |
| 1990's | 11 (20.37) | 18.2507 |
| 2000's | 27 (50.00) | 29.6817 |
| 2010's | 5 (9.26) | 24.3611 |
| 2020's | 1 (1.85) | 2.80 |
| Authors | Studies |
|---|---|
| Chock, VY | 1 |
| Cho, SH | 1 |
| Frymoyer, A | 1 |
| Mousavi, SS | 1 |
| Zadeh, MH | 1 |
| Shahbazian, H | 1 |
| Khanzadeh, A | 1 |
| Hayati, F | 1 |
| Ghorbani, A | 1 |
| Golzari, K | 1 |
| Valavi, E | 1 |
| Motemednia, F | 1 |
| Mousavi, MB | 1 |
| Sterling, KA | 1 |
| Tehrani, T | 1 |
| Rudnick, MR | 1 |
| Baskurt, M | 1 |
| Okcun, B | 1 |
| Abaci, O | 1 |
| Dogan, GM | 1 |
| Kilickesmez, K | 1 |
| Ozkan, AA | 1 |
| Ersanli, M | 1 |
| Gurmen, T | 1 |
| Malhis, M | 1 |
| Al-Bitar, S | 1 |
| Al-Deen Zaiat, K | 1 |
| Matejka, J | 1 |
| Varvarovsky, I | 1 |
| Vojtisek, P | 1 |
| Herman, A | 1 |
| Rozsival, V | 1 |
| Borkova, V | 1 |
| Kvasnicka, J | 1 |
| Bilasy, ME | 1 |
| Oraby, MA | 1 |
| Ismail, HM | 1 |
| Maklady, FA | 1 |
| Kwok, CS | 1 |
| Pang, CL | 1 |
| Yeong, JK | 1 |
| Loke, YK | 1 |
| Kapoor, A | 1 |
| Kumar, S | 1 |
| Gulati, S | 1 |
| Gambhir, S | 1 |
| Sethi, RS | 1 |
| Sinha, N | 1 |
| Tello, R | 1 |
| Huber, W | 4 |
| Schipek, C | 1 |
| Ilgmann, K | 3 |
| Page, M | 3 |
| Hennig, M | 3 |
| Wacker, A | 2 |
| Schweigart, U | 3 |
| Lutilsky, L | 2 |
| Valina, C | 1 |
| Seyfarth, M | 1 |
| Schömig, A | 1 |
| Classen, M | 3 |
| McLaughlin, GE | 2 |
| Schober, M | 1 |
| Perez, M | 1 |
| Ruiz, P | 1 |
| Steele, BW | 1 |
| Abitbol, C | 1 |
| BAUER, KM | 1 |
| MILLASANTOS, J | 1 |
| DARNELLTEY, A | 1 |
| MARZETTI, L | 2 |
| BENAGIANO, G | 1 |
| Ix, JH | 1 |
| McCulloch, CE | 1 |
| Chertow, GM | 1 |
| Benoehr, P | 1 |
| Krueth, P | 1 |
| Bokemeyer, C | 1 |
| Grenz, A | 1 |
| Osswald, H | 2 |
| Hartmann, JT | 1 |
| Nishihara, K | 1 |
| Bagshaw, SM | 1 |
| Ghali, WA | 1 |
| Bakr, AF | 1 |
| van den Berk, G | 1 |
| Tonino, S | 1 |
| de Fijter, C | 1 |
| Smit, W | 1 |
| Schultz, MJ | 2 |
| Cattarelli, D | 1 |
| Spandrio, M | 1 |
| Gasparoni, A | 1 |
| Bottino, R | 1 |
| Offer, C | 1 |
| Chirico, G | 1 |
| Alva, MD | 1 |
| Egea, M | 1 |
| Pannu, N | 1 |
| Tonelli, M | 1 |
| Dussol, B | 1 |
| Morange, S | 1 |
| Loundoun, A | 1 |
| Auquier, P | 1 |
| Berland, Y | 1 |
| Eckel, F | 1 |
| Rosenbrock, H | 1 |
| Saur, D | 1 |
| Sennefelder, A | 1 |
| Hennico, R | 1 |
| Schenk, C | 1 |
| Meining, A | 1 |
| Schmelz, R | 1 |
| Fritsch, R | 1 |
| Weiss, W | 3 |
| Hamar, P | 1 |
| Heemann, U | 1 |
| Schmid, RM | 1 |
| Erley, C | 1 |
| Pucelikova, T | 1 |
| Dangas, G | 1 |
| Mehran, R | 1 |
| Joannidis, M | 1 |
| Blouin, RA | 1 |
| Elgert, JF | 1 |
| Bauer, LA | 1 |
| Morcos, SK | 2 |
| Brown, PW | 1 |
| Drescher, P | 1 |
| Pereira, F | 1 |
| Will, JA | 1 |
| Madsen, PO | 1 |
| Katholi, RE | 1 |
| Taylor, GJ | 1 |
| McCann, WP | 1 |
| Woods, WT | 1 |
| Womack, KA | 1 |
| McCoy, CD | 1 |
| Katholi, CR | 1 |
| Moses, HW | 1 |
| Mishkel, GJ | 1 |
| Lucore, CL | 1 |
| Kudoh, S | 1 |
| Satoh, A | 1 |
| Liebl, R | 1 |
| Krämer, BK | 2 |
| Nolan, DB | 1 |
| Quasny, H | 1 |
| Erley, CM | 1 |
| Duda, SH | 1 |
| Rehfuss, D | 1 |
| Scholtes, B | 1 |
| Bock, J | 1 |
| Müller, C | 1 |
| Risler, T | 1 |
| Jenik, AG | 1 |
| Ceriani Cernadas, JM | 1 |
| Gorenstein, A | 1 |
| Ramirez, JA | 1 |
| Vain, N | 1 |
| Armadans, M | 1 |
| Ferraris, JR | 1 |
| Prévot, A | 2 |
| Semama, DS | 2 |
| Tendron, A | 1 |
| Justrabo, E | 1 |
| Guignard, JP | 2 |
| Gouyon, JB | 2 |
| Jeschke, B | 2 |
| Salmhofer, H | 2 |
| Reichenberger, J | 1 |
| Neu, B | 1 |
| Preuner, J | 1 |
| Ebenburger, A | 1 |
| Kaiser, M | 1 |
| Bergner, U | 1 |
| Eilles, C | 1 |
| Kammerl, MC | 1 |
| Riegger, GA | 1 |
| Birnbaum, DE | 1 |
| Huet, F | 1 |
| Gerdes, H | 1 |
| Mamikonian, RS | 1 |
| Barsegian, BA | 1 |
| Tumanian, AM | 1 |
| Arutiunian, VM | 1 |
| Basmadzhian, NM | 1 |
| Gandhi, MR | 1 |
| Brown, P | 1 |
| Romanowski, CA | 1 |
| Campbell, S | 1 |
| el Nahas, AM | 1 |
| Gray, TA | 1 |
| Sawaya, BP | 1 |
| Weihprecht, H | 1 |
| Campbell, WR | 1 |
| Lorenz, JN | 1 |
| Webb, RC | 1 |
| Briggs, JP | 1 |
| Schnermann, J | 1 |
| Epstein, FH | 1 |
| Rosen, S | 1 |
| Galicka-Piskorska, G | 1 |
| Spokes, K | 1 |
| Brezis, M | 1 |
| Silva, P | 1 |
| Seideman, P | 1 |
| Sollevi, A | 1 |
| Fredholm, BB | 1 |
| Ross, CA | 1 |
| Kraft, CJ | 1 |
| Lee, MH | 1 |
| Haughey, DB | 1 |
| Leopold, D | 1 |
| Webb, D | 1 |
| Buss, DC | 1 |
| Fifield, RA | 1 |
| Smith, AP | 1 |
| Routledge, PA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia[NCT05295784] | Phase 1 | 18 participants (Anticipated) | Interventional | 2024-06-30 | Not yet recruiting | ||
| The Effect of Aminophylline on Preventing Acute Kidney Injury in Pediatric Patients Undergoing Open Heart Surgery[NCT03897335] | Phase 3 | 80 participants (Anticipated) | Interventional | 2019-02-07 | Recruiting | ||
| [NCT02276170] | 9 participants (Actual) | Observational | 2014-10-31 | Terminated (stopped due to insufficient rate of accrual) | |||
| Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging[NCT02114697] | Phase 4 | 9 participants (Actual) | Interventional | 2014-04-30 | Terminated (stopped due to The study was stopped when the original principal investigator moved to a new institution.) | ||
| Efficacy of Oral Sodium Chloride vs iv Sodium Chloride in the Prevention of Contrast Nephropathy in Outpatients[NCT03476460] | Phase 2 | 269 participants (Actual) | Interventional | 2014-03-01 | Completed | ||
| Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
| Pre-existing Microalbuminuria Predicting Contrast-induced Acute Kidney Injury (CIAKI) Following Coronary Angiography (CAG)[NCT02808845] | 800 participants (Anticipated) | Observational | 2016-12-31 | Not yet recruiting | |||
| Early Detection of Contrast Induced Nephropathy After Coronary Angiography : Predictive Value of Osteopontin[NCT05547581] | 155 participants (Anticipated) | Observational | 2022-12-07 | Not yet recruiting | |||
| Perioperative Aminophylline to Improve High Risk Renal Graft Outcome- a Double Blinded, Placebo Controlled, Randomized Clinical Trial[NCT01759862] | 50 participants (Actual) | Interventional | 2012-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Plaque volume of carotid arteries were measured by MRI as a surrogate for progression of cardiovascular disease. Plaque volume varies with observed ranges from other studies ranging from 23.9 to 604.1mm^3. Plaque volume tends to increase with age. Increased plaque volume has an increased risk of vascular events. (NCT02114697)
Timeframe: Baseline, 18 months, 36 months
| Intervention | Cubic millimeter (mm^3) (Mean) |
|---|---|
| Baseline | |
| Lifestyle Modification | 125.18 |
Plaque volume of carotid arteries were measured by MRI as a surrogate for progression of cardiovascular disease. Plaque volume varies with observed ranges from other studies ranging from 23.9 to 604.1mm^3. Plaque volume tends to increase with age. Increased plaque volume has an increased risk of vascular events. (NCT02114697)
Timeframe: Baseline, 18 months, 36 months
| Intervention | Cubic millimeter (mm^3) (Mean) | |
|---|---|---|
| Baseline | Month 18 | |
| Statin Therapy | 108.88 | 114.70 |
The investigators will measure blood creatinine on post-operative day 5 and using the Schwartz equation will calculate estimated glomerular filtration rate (GFR) to determine kidney function. (NCT01759862)
Timeframe: 5 days
| Intervention | ml/min/1.73m2 (Mean) |
|---|---|
| Aminophylline | 67.39 |
| Control | 80.48 |
The investigators will use the same cores that are obtained during routine 6 months protocol biopsies to quantify the amount of fibrosis (NCT01759862)
Timeframe: 6 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Aminophylline | 11 |
| Control | 14 |
urinary NGAL(Neutrophil gelatinase-associated lipocalin) is a biomarker for kidney injury. NGAL levels 12h post-transplant were found to be a marker for development of delayed graft function and need for dialysis post-transplant. NGAL levels are corrected for urine creatinine. (NCT01759862)
Timeframe: 12 hours post transplant
| Intervention | ng/mg (Median) |
|---|---|
| Aminophylline | 300.5 |
| Control | 425.4 |
11 reviews available for theophylline and Kidney Diseases
| Article | Year |
|---|---|
Clinical significance and preventive strategies for contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Contrast Med | 2008 |
Measures used to treat contrast-induced nephropathy: overview of reviews.
Topics: Acetylcysteine; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxymethylglutaryl-CoA R | 2013 |
Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis.
Topics: Aminophylline; Contrast Media; Creatinine; Humans; Kidney Diseases; Kidney Failure, Chronic; Randomi | 2004 |
[Bronchodilator: theophylline].
Topics: Aging; Asthma; Biomarkers; Bronchodilator Agents; Dosage Forms; Drug Interactions; Drug Monitoring; | 2004 |
Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.
Topics: Angiography; Contrast Media; Humans; Incidence; Kidney Diseases; Randomized Controlled Trials as Top | 2005 |
Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.
Topics: Acetylcysteine; Contrast Media; Critical Care; Fenoldopam; Free Radical Scavengers; Hemofiltration; | 2005 |
Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.
Topics: Acetylcysteine; Ascorbic Acid; Contrast Media; Evidence-Based Medicine; Fenoldopam; Humans; Kidney D | 2006 |
[Iodinated contrast agent-induced nephropathy].
Topics: Acetylcysteine; Acute Kidney Injury; Age Factors; Angiography; Clinical Trials as Topic; Contrast Me | 2007 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; | 2008 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; | 2008 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; | 2008 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; | 2008 |
Medical therapy of acute kidney injury.
Topics: Acute Kidney Injury; Antioxidants; Contrast Media; Diuretics; Diuretics, Osmotic; Erythropoietin; Hu | 2007 |
[Complications after administration of contrast media in high-risk patients. Is a prophylactic dialysis meaningful?].
Topics: Atrial Natriuretic Factor; Calcium Channel Blockers; Contrast Media; Endothelin Receptor Antagonists | 1996 |
19 trials available for theophylline and Kidney Diseases
| Article | Year |
|---|---|
The protective effect of theophyline in cisplatin nephrotoxicity.
Topics: Aged; Antineoplastic Agents; Cisplatin; Cross-Sectional Studies; Double-Blind Method; Female; Humans | 2014 |
N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Drug Therapy, Combination; Female; Human | 2009 |
The role of theophylline in prevention of radiocontrast media-induced nephropathy.
Topics: Adenosine; Administration, Oral; Adult; Aged; Biomarkers; Contrast Media; Creatinine; Female; Glomer | 2010 |
Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease.
Topics: Acute Kidney Injury; Age Factors; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Biomarker | 2010 |
Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Topics: Acetylcysteine; Adult; Aged; Contrast Media; Coronary Angiography; Creatinine; Drug Therapy, Combina | 2012 |
The role of theophylline in contrast-induced nephropathy: a case-control study.
Topics: Administration, Oral; Adult; Aged; Blood Urea Nitrogen; Case-Control Studies; Contrast Media; Corona | 2002 |
Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.
Topics: Adenosine; Aged; Contrast Media; Coronary Angiography; Creatinine; Endpoint Determination; Female; H | 2003 |
Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, | 2005 |
Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia--a study in a developing country.
Topics: Asphyxia Neonatorum; Chemoprevention; Developing Countries; Double-Blind Method; Humans; Infant, New | 2005 |
Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia--a study in a developing country.
Topics: Asphyxia Neonatorum; Chemoprevention; Developing Countries; Double-Blind Method; Humans; Infant, New | 2005 |
Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia--a study in a developing country.
Topics: Asphyxia Neonatorum; Chemoprevention; Developing Countries; Double-Blind Method; Humans; Infant, New | 2005 |
Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia--a study in a developing country.
Topics: Asphyxia Neonatorum; Chemoprevention; Developing Countries; Double-Blind Method; Humans; Infant, New | 2005 |
A randomised, double blind, placebo controlled trial of the effect of theophylline in prevention of vasomotor nephropathy in very preterm neonates with respiratory distress syndrome.
Topics: Creatinine; Double-Blind Method; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Blood Urea Nitrogen; Contrast Media; Creatinine; Cri | 2006 |
Nephrotoxicity from contrast media: attenuation with theophylline.
Topics: Adenosine; Creatinine; Diatrizoate; Dipyridamole; Humans; Iopamidol; Kidney; Kidney Diseases; Middle | 1995 |
Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline.
Topics: Acetylglucosaminidase; Adenosine; Aged; Combined Modality Therapy; Contrast Media; Creatinine; Doubl | 1999 |
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
Topics: Asphyxia Neonatorum; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidne | 2000 |
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
Topics: Asphyxia Neonatorum; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidne | 2000 |
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
Topics: Asphyxia Neonatorum; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidne | 2000 |
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
Topics: Asphyxia Neonatorum; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidne | 2000 |
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
Topics: Asphyxia Neonatorum; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidne | 2000 |
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
Topics: Asphyxia Neonatorum; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidne | 2000 |
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
Topics: Asphyxia Neonatorum; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidne | 2000 |
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
Topics: Asphyxia Neonatorum; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidne | 2000 |
A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia.
Topics: Asphyxia Neonatorum; Double-Blind Method; Glomerular Filtration Rate; Humans; Infant, Newborn; Kidne | 2000 |
Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk.
Topics: Adenosine; Aged; Contrast Media; Female; Germany; Humans; Incidence; Intensive Care Units; Kidney Di | 2001 |
Lack of renoprotective effect of theophylline during aortocoronary bypass surgery.
Topics: Blood Pressure; Coronary Artery Bypass; Creatinine; Cytoprotection; Diuresis; Double-Blind Method; D | 2002 |
Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Creatinine; Double-Blind Me | 2002 |
The use of theophylline, an adenosine antagonist in the prevention of contrast media induced nephrotoxicity.
Topics: Adenosine; Adult; Aged; Contrast Media; Female; Humans; Kidney Diseases; Male; Middle Aged; Theophyl | 1992 |
24 other studies available for theophylline and Kidney Diseases
| Article | Year |
|---|---|
Aminophylline for renal protection in neonatal hypoxic-ischemic encephalopathy in the era of therapeutic hypothermia.
Topics: Acute Kidney Injury; Aminophylline; Asphyxia Neonatorum; Biomarkers; Creatinine; Female; Humans; Hyp | 2021 |
Intrarenal kinetics: effect of adenosine and theophylline.
Topics: Adenosine; Contrast Media; Humans; Kidney Diseases; Kidney Failure, Chronic; Theophylline; Vasodilat | 2003 |
Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats.
Topics: Adenosine; Animals; Creatinine; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Rats; Rats, | 2003 |
[Clinical experience with a new theophylline derivative combined with a new spasmolytic in the treatment of renal insufficiency].
Topics: Cardiovascular Agents; Kidney Diseases; Muscle Relaxants, Central; Parasympatholytics; Renal Insuffi | 1957 |
[RESULTS OF CLINICAL EXPERIMENTATION WITH AC 3810 (TRENTADIL)].
Topics: Adolescent; Asthma; Biliary Tract; Biomedical Research; Colic; Dysmenorrhea; Female; Geriatrics; Hum | 1964 |
[POSSIBILITIES AND ADVANTAGES OF FIBRINOLYTIC DRUGS IN THERAPY OF KIDNEY DISEASE IN PREGNANCY].
Topics: Blood Coagulation Disorders; Drug Therapy; Female; Fibrinolysis; Fibrinolytic Agents; Humans; Kidney | 1964 |
[INTRAVASCULAR COAGULATION AND FIBRINOLYSIS. EXPERIMENTAL CONTRIBUTION TO THE STUDY OF TREATMENT OF KIDNEY DISEASE IN PREGNANCY].
Topics: Animals; Blood Coagulation; Blood Coagulation Disorders; Female; Fibrinolysis; Humans; Kidney; Kidne | 1964 |
Adenosine receptor antagonism in acute tacrolimus toxicity.
Topics: Animals; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Purinergic P | 2006 |
N-acetylcysteine and/or theophylline as a preventive measure for contrast agent induced nephropathy: we should use better markers for detection of renal function.
Topics: Acetylcysteine; Biomarkers; Contrast Media; Free Radical Scavengers; Humans; Kidney Diseases; Phosph | 2007 |
Theophylline clearance: effect of marked obesity.
Topics: Adult; Aged; Body Weight; Female; Heart Failure; Humans; Kidney Diseases; Male; Metabolic Clearance | 1980 |
Nephrotoxicity from contrast media: attenuation with theophylline.
Topics: Adenosine; Contrast Media; Creatinine; Diatrizoate; Glomerular Filtration Rate; Humans; Iopamidol; K | 1995 |
Nephrotoxicity from contrast media: attenuation with theophylline.
Topics: Adenosine; Age Factors; Contrast Media; Humans; Kidney; Kidney Diseases; Middle Aged; Phosphodiester | 1995 |
[Basic studies on the prevention of cyclosporin A induced nephrotoxicity].
Topics: Animals; Cyclosporine; Diltiazem; Humans; Kidney; Kidney Diseases; Lymphocyte Activation; Male; Rats | 1994 |
Theophylline option for attenuating contrast media-induced nephrotoxicity in patients on metformin.
Topics: Acidosis, Lactic; Contraindications; Contrast Media; Diabetes Mellitus, Type 2; Humans; Hypoglycemic | 1997 |
Metformin, contrast media, and theophylline.
Topics: Acidosis, Lactic; Contraindications; Contrast Media; Diabetes Mellitus, Type 2; Humans; Hypoglycemic | 1997 |
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosp | 2000 |
Complementary effects of adenosine and angiotensin II in hypoxemia-induced renal dysfunction in the rabbit.
Topics: Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Gas Analysis; Hy | 2002 |
[Symptomatology and therapy of lithium intoxication].
Topics: Aged; Anticonvulsants; Bipolar Disorder; Deglutition Disorders; Female; Humans; Kidney Diseases; Lit | 1978 |
[Use of complamin in nephrological practice].
Topics: Adult; Chronic Disease; Diuresis; Female; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Theoph | 1979 |
Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Relation of adenosine to medullary injury in the perfused rat kidney.
Topics: Adenosine; Adenosine Deaminase; Animals; Biological Transport; Kidney Diseases; Kidney Medulla; Male | 1990 |
Additive renal effects of indomethacin and dipyridamole in man.
Topics: Adenosine; Adolescent; Adult; Body Water; Dipyridamole; Diuresis; Drug Interactions; Female; Glomeru | 1987 |
Evaluation of a mouse monoclonal antibody for the determination of serum theophylline by fluorescence polarization immunoassay.
Topics: Animals; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Fluorescence Polarization; Fl | 1985 |
The ex vivo plasma protein binding of theophylline in renal disease.
Topics: Adult; Blood Proteins; Humans; Kidney Diseases; Middle Aged; Theophylline | 1985 |